Blair William & CO Bristol Myers Squibb CO Transaction History

Blair William & CO

$33.4 Billion
Q3 2024

A detailed history of Blair William & CO transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Blair William & CO holds 536,724 shares of BMY stock, worth $31 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares

536,724

Previous 582,159 7.8%

Holding current value

$31 Million

Previous $24.2 Million 14.88%

% of portfolio

0.08%

Previous 0.08%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$39.66 - $51.75 $1.8 Million - $2.35 Million	-45,435 Reduced 7.8%	536,724 $27.8 Million
Q2 2024 Aug 12, 2024	SELL	$40.25 - $52.99 $3.76 Million - $4.95 Million	-93,451 Reduced 13.83%	582,159 $24.2 Million
Q1 2024 May 09, 2024	SELL	$47.98 - $54.4 $9.06 Million - $10.3 Million	-188,760 Reduced 21.84%	675,610 $36.6 Million
Q4 2023 Feb 12, 2024	SELL	$48.48 - $57.85 $12.8 Million - $15.3 Million	-264,198 Reduced 23.41%	864,370 $44.4 Million
Q3 2023 Nov 09, 2023	SELL	$57.89 - $64.73 $3.39 Million - $3.79 Million	-58,545 Reduced 4.93%	1,128,568 $65.5 Million
Q2 2023 Aug 11, 2023	SELL	$63.71 - $70.74 $2.03 Million - $2.26 Million	-31,934 Reduced 2.62%	1,187,113 $75.9 Million
Q1 2023 May 12, 2023	BUY	$65.71 - $74.53 $529,162 - $600,190	8,053 Added 0.66%	1,219,047 $84.5 Million
Q4 2022 Feb 10, 2023	SELL	$68.48 - $81.09 $4.4 Million - $5.21 Million	-64,269 Reduced 5.04%	1,210,994 $87.1 Million
Q3 2022 Nov 09, 2022	BUY	$0.13 - $76.84 $2,074 - $1.23 Million	15,960 Added 1.27%	1,275,263 $90.7 Million
Q2 2022 Aug 10, 2022	BUY	$72.62 - $79.98 $12.8 Million - $14.1 Million	176,326 Added 16.28%	1,259,303 $97 Million
Q1 2022 May 13, 2022	BUY	$61.48 - $73.72 $143,863 - $172,504	2,340 Added 0.22%	1,082,977 $79.1 Million
Q4 2021 Feb 14, 2022	SELL	$53.63 - $62.52 $9.65 Million - $11.2 Million	-179,866 Reduced 14.27%	1,080,637 $67.4 Million
Q3 2021 Nov 12, 2021	SELL	$59.17 - $69.31 $10.3 Million - $12.1 Million	-174,033 Reduced 12.13%	1,260,503 $74.6 Million
Q2 2021 Aug 12, 2021	BUY	$61.91 - $67.42 $515,710 - $561,608	8,330 Added 0.58%	1,434,536 $95.9 Million
Q1 2021 May 13, 2021	BUY	$59.34 - $66.74 $1.83 Million - $2.05 Million	30,778 Added 2.21%	1,426,206 $90 Million
Q4 2020 Feb 09, 2021	BUY	$57.74 - $65.43 $3.48 Million - $3.94 Million	60,211 Added 4.51%	1,395,428 $86.6 Million
Q3 2020 Nov 06, 2020	BUY	$57.43 - $63.64 $5.38 Million - $5.97 Million	93,741 Added 7.55%	1,335,217 $80.5 Million
Q2 2020 Aug 12, 2020	BUY	$54.82 - $64.09 $14.8 Million - $17.3 Million	269,624 Added 27.74%	1,241,476 $73 Million
Q1 2020 May 11, 2020	BUY	$46.4 - $67.43 $4.64 Million - $6.74 Million	99,922 Added 11.46%	971,852 $54.2 Million
Q4 2019 Feb 13, 2020	BUY	$49.21 - $64.19 $11.4 Million - $14.8 Million	231,285 Added 36.1%	871,930 $56 Million
Q3 2019 Nov 12, 2019	SELL	$42.77 - $50.71 $297,978 - $353,296	-6,967 Reduced 1.08%	640,645 $32.5 Million
Q2 2019 Aug 13, 2019	BUY	$44.62 - $49.34 $687,058 - $759,737	15,398 Added 2.44%	647,612 $29.4 Million
Q1 2019 May 14, 2019	BUY	$45.12 - $53.8 $1.43 Million - $1.71 Million	31,772 Added 5.29%	632,214 $30.2 Million
Q4 2018 Feb 14, 2019	SELL	$48.76 - $63.23 $3.3 Million - $4.28 Million	-67,639 Reduced 10.12%	600,442 $31.2 Million
Q3 2018 Nov 13, 2018	SELL	$55.19 - $62.25 $347,697 - $392,175	-6,300 Reduced 0.93%	668,081 $41.5 Million
Q2 2018 Aug 13, 2018	SELL	$50.53 - $62.98 $2.17 Million - $2.71 Million	-43,011 Reduced 6.0%	674,381 $37.3 Million
Q1 2018 May 15, 2018	SELL	$59.92 - $68.98 $2.76 Million - $3.18 Million	-46,085 Reduced 6.04%	717,392 $45.4 Million
Q4 2017 Feb 14, 2018	BUY	$59.94 - $65.35 $1.37 Million - $1.49 Million	22,832 Added 3.08%	763,477 $46.8 Million
Q3 2017 Nov 13, 2017	BUY	$55.23 - $63.74 $40.9 Million - $47.2 Million	740,645	740,645 $47.2 Million

Others Institutions Holding BMY

# of Institutions

2,536

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $123B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Blair William & CO, based on Form 13F filings with the SEC.

News

Stay updated on Blair William & CO with notifications on news.

Account